Oxurion NV (OXUR) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.097x

Based on the latest financial reports, Oxurion NV (OXUR) has a cash flow conversion efficiency ratio of 0.097x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.16 Million ≈ $-1.36 Million USD) by net assets (€-11.99 Million ≈ $-14.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Oxurion NV - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Oxurion NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Oxurion NV balance sheet liabilities for a breakdown of total debt and financial obligations.

Oxurion NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oxurion NV ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guess? Inc. NYSE:GES	-0.070x
Pebble Beach Systems Group PLC LSE:PEB	-7.815x
Rivalry Corp V:RVLY	-0.004x
Works co uk PLC LSE:WRKS	1.780x
SMG EUROPEAN RECOV. EO 1 F:RCVR	N/A
GETT Gold Inc V:GETT	-0.004x
Wyld Networks AB ST:WYLD	-2.557x
SkinBioTherapeutics PLC LSE:SBTX	-0.053x

Annual Cash Flow Conversion Efficiency for Oxurion NV (2006–2024)

The table below shows the annual cash flow conversion efficiency of Oxurion NV from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see OXUR market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-11.06 Million ≈ $-12.93 Million	€-2.07 Million ≈ $-2.42 Million	0.187x	-74.75%
2023-12-31	€-13.19 Million ≈ $-15.42 Million	€-9.77 Million ≈ $-11.42 Million	0.741x	-83.04%
2022-12-31	€-4.58 Million ≈ $-5.36 Million	€-20.02 Million ≈ $-23.40 Million	4.367x	-82.18%
2021-12-31	€-1.11 Million ≈ $-1.30 Million	€-27.16 Million ≈ $-31.75 Million	24.508x	+2365.49%
2020-12-31	€25.05 Million ≈ $29.28 Million	€-27.10 Million ≈ $-31.68 Million	-1.082x	-85.42%
2019-12-31	€53.31 Million ≈ $62.32 Million	€-31.10 Million ≈ $-36.36 Million	-0.583x	-97.46%
2018-12-31	€105.31 Million ≈ $123.12 Million	€-31.12 Million ≈ $-36.38 Million	-0.295x	-249.85%
2017-12-31	€133.36 Million ≈ $155.91 Million	€26.30 Million ≈ $30.74 Million	0.197x	+206.66%
2016-12-31	€109.86 Million ≈ $128.44 Million	€-20.31 Million ≈ $-23.74 Million	-0.185x	-13.08%
2015-12-31	€170.01 Million ≈ $198.77 Million	€-27.79 Million ≈ $-32.49 Million	-0.163x	+27.00%
2014-12-31	€208.01 Million ≈ $243.19 Million	€-46.58 Million ≈ $-54.46 Million	-0.224x	-325.38%
2013-12-31	€258.77 Million ≈ $302.53 Million	€25.71 Million ≈ $30.06 Million	0.099x	-18.50%
2012-12-31	€227.97 Million ≈ $266.52 Million	€27.79 Million ≈ $32.49 Million	0.122x	+173.54%
2011-12-31	€118.03 Million ≈ $137.99 Million	€-19.56 Million ≈ $-22.87 Million	-0.166x	-36.00%
2010-12-31	€138.19 Million ≈ $161.56 Million	€-16.84 Million ≈ $-19.69 Million	-0.122x	+5.59%
2009-12-31	€93.72 Million ≈ $109.57 Million	€-12.10 Million ≈ $-14.14 Million	-0.129x	-167.36%
2008-12-31	€62.39 Million ≈ $72.94 Million	€11.96 Million ≈ $13.98 Million	0.192x	+162.73%
2007-12-31	€48.44 Million ≈ $56.63 Million	€-14.80 Million ≈ $-17.30 Million	-0.306x	-28.03%
2006-12-31	€35.28 Million ≈ $41.24 Million	€-8.42 Million ≈ $-9.84 Million	-0.239x	--

About Oxurion NV

BR:OXUR Belgium Biotechnology

Market Cap

$311.42K

€266.37K EUR

Market Cap Rank

#30701 Global

#113 in Belgium

Share Price

€0.00

Change (1 day)

-5.00%

52-Week Range

€0.00 - €0.08

All Time High

€102000.00